文献速递神经肿瘤

WHO 2级脑膜瘤切除程度与生存结局

Extent of resection and survival outcomes in World Health Organization grade II meningiomas.
PubMed 文献 · J Neurooncol · 2020-11-17

该回顾性队列纳入1995—2019年在本机构接受手术切除的颅内WHO 2级脑膜瘤患者214例,中位随访53.4个月,其中全切除158例、次全切除56例。Kaplan-Meier分析显示全切除组无进展生存(p=0.002)与总生存(p=0.006)均显著优于次全切除组;多因素Cox分析在控制年龄、肿瘤部位和辅助放疗后,全切除仍独立预测更长的无进展生存(HR 0.57,p=0.038)与总生存(HR 0.44,p=0.017)。作者认为最大安全切除应作为此类患者治疗的首要目标。

要点

  • WHO 2级脑膜瘤中,全切除与更长的无进展生存和总生存独立相关。
  • 多因素校正年龄、部位与辅助放疗后,全切除的生存获益仍存在。
  • 在辅助治疗日益受重视的背景下,最大安全切除仍是主要治疗目标。

核心结论

  • 切除程度独立预测WHO 2级脑膜瘤患者的无进展生存与总生存。
  • 数据支持将最大安全切除作为此类患者治疗的首要目标。

研究设计与样本

  • 单中心回顾性数据库研究,纳入1995—2019年接受手术切除的颅内WHO 2级脑膜瘤患者214例。
  • 中位随访53.4个月;全切除158例,次全切除56例;采用Kaplan-Meier分析与多因素Cox比例风险分析。

主要发现

  • Kaplan-Meier分析中,全切除组无进展生存显著长于次全切除组(p=0.002)。
  • Kaplan-Meier分析中,全切除组总生存显著长于次全切除组(p=0.006)。
  • 多因素Cox分析控制年龄、肿瘤部位和辅助放疗后,全切除独立预测更长的无进展生存(HR 0.57,p=0.038)。
  • 多因素Cox分析中,全切除独立预测更长的总生存(HR 0.44,p=0.017)。

关键数值与推荐

  • WHO 2级脑膜瘤复发率可高达60%。
  • 全切除与次全切除的无进展生存比较:p=0.002;总生存比较:p=0.006。
  • 多因素分析中全切除对无进展生存的HR 0.57(p=0.038),对总生存的HR 0.44(p=0.017)。

临床怎么用

  • 对WHO 2级脑膜瘤,在安全前提下应争取全切除以改善无进展生存与总生存。
  • 术后辅助放疗决策需结合切除程度、年龄与肿瘤部位综合评估。

局限性

  • 为单中心回顾性研究,证据等级受设计限制。
  • 样本来自单一机构1995—2019年病例,外推性需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: WHO grade II meningiomas behave aggressively, with recurrence rates as high as 60%. Although complete resection in low-grade meningiomas is associated with a relatively low recurrence rate, the impact of complete resection for WHO grade II meningiomas is less clear. We studied the association of extent of resection with overall and progression-free survivals in patients with WHO grade II meningiomas. METHODS: A retrospective database review was performed to identify all patients who underwent surgical resection for intracranial WHO grade II meningiomas at our institution between 1995 and 2019. Kaplan-Meier analysis was used to compare overall and progression-free survivals between patients who underwent gross total resection (GTR) and those who underwent subtotal resection (STR). Multivariable Cox proportional-hazards analysis was used to identify independent predictors of tumor recurrence and mortality. RESULTS: Of 214 patients who underwent surgical resection for WHO grade II meningiomas (median follow-up 53.4 months), 158 had GTR and 56 had STR. In Kaplan-Meier analysis, patients who underwent GTR had significantly longer progression-free (p = 0.002) and overall (p = 0.006) survivals than those who underwent STR. In multivariable Cox proportional-hazards analysis, GTR independently predicted prolonged progression-free (HR 0.57, p = 0.038) and overall (HR 0.44, p = 0.017) survivals when controlling for age, tumor location, and adjuvant radiation. CONCLUSIONS: Extent of resection independently predicts progression-free and overall survivals in patients with WHO grade II meningiomas. In an era of increasing support for adjuvant treatment modalities in the management of meningiomas, our data support maximal safe resection as the primary goal in treatment of these patients.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Soni P, Davison MA, Shao J, et al. Extent of resection and survival outcomes in World Health Organization grade II meningiomas. J Neurooncol. 2020. PMID: 33205354. doi:10.1007/s11060-020-03632-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。